The Neuromodulation Market is a rapidly growing sector in the healthcare industry, focused on the use of technology to modify or regulate the function of the nervous system. Neuromodulation therapy involves the use of implantable devices or non-invasive techniques to stimulate or inhibit specific areas of the brain or spinal cord. The increasing prevalence of neurological disorders such as...

Acute dystonia is a neurological movement disorder characterized by involuntary muscle contractions and twisting postures. It is caused by damage to the areas of the brain that control muscle tone and movement, known as the basal ganglia. The basal ganglia normally work to inhibit involuntary movements - when they are damaged or certain drugs interfere with their function, it can lead to...

The global neuroleptics market  refers to the pharmaceutical sector that focuses on the production, distribution, and sales of neuroleptic drugs, also known as antipsychotics. Neuroleptics are a class of medications primarily used in the treatment of neurological and psychiatric disorders, including schizophrenia, bipolar disorder, and certain types of dementia. The neuroleptics...

The Neuromodulation Market is a rapidly growing sector in the healthcare industry, focused on the use of technology to modify or regulate the function of the nervous system. Neuromodulation therapy involves the use of implantable devices or non-invasive techniques to stimulate or inhibit specific areas of the brain or spinal cord. The increasing prevalence of neurological disorders such as...

What is it?Global spastic paraplegia 50 (SPG50) is a rare, progressive neurological disorder that causes weakness and stiffness (spasticity) in the lower limbs. It belongs to a family of genetic conditions called hereditary spastic paraplegias (HSPs), which are characterized by stiff, rigid muscles in the legs along with weakness. SPG50 is caused by mutations in the MAP1B gene, which provides...